Amosulalol hydrochloride long acting formulation

Details Amosulalol hydrochloride long acting formulation Amosulalol hydrochloride long acting formulation

1986-11-14

1988-02-09

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

424481, 424482, A61K 932, A61K 936, A61K 934

Patent

active

047241489

ABSTRACT:
Long acting formulations of amosulalol hydrochloride are provided, wherein the frequency of administering the hypotensive agent is minimized and wherein such formulations are prepared by compounding amosulalol hydrochloride with an enterosoluble material and optionally the inclusion of an organic acid.

REFERENCES:
patent: 3520970 (1970-07-01), Lehmann et al.
patent: 3538214 (1970-11-01), Polli et al.
patent: 3775537 (1973-11-01), Lehmann et al.
patent: 3835221 (1974-09-01), Fulberth et al.
patent: 3954959 (1976-05-01), Pedersen
patent: 4083949 (1978-04-01), Benedikt
patent: 4289750 (1981-09-01), Kopp et al.
patent: 4361546 (1982-11-01), Stricker et al.
patent: 4367217 (1983-01-01), Gruber et al.
patent: 4427648 (1984-01-01), Brickl et al.
patent: 4438091 (1984-03-01), Gruber et al.

Affiliated with

Also associated with

Rating

Amosulalol hydrochloride long acting formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amosulalol hydrochloride long acting formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amosulalol hydrochloride long acting formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1283501